Stryker Q3 beats: adj EPS $2.87 (+16.7%), sales $5.5B (+11.5% organic), raises FY guidance

STRYKER CORP

2024-Q3 EPS reported $6.35 revenue$16,159,000,000

Reported net sales $5.5B, +11.9% reported, +11.5% organic; adjusted EPS $2.87, +16.7%.
Adjusted operating margin expanded 130bps to 24.7%.
MedSurg & Neurotechnology organic sales +12.7%; Orthopaedics & Spine +9.7%.
FY2024 guidance raised: organic sales growth 9.5%-10.0%, adjusted EPS $12.00-$12.10.
CEO cites product innovation and acquisitions as growth drivers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.